|
CNIH expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.656600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.099200E-01 |
| Normal-vs-Stage2 |
5.817200E-01 |
| Normal-vs-Stage3 |
2.330200E-02 |
| Normal-vs-Stage4 |
1.077840E-02 |
| Stage1-vs-Stage2 |
4.051800E-01 |
| Stage1-vs-Stage3 |
7.122400E-03 |
| Stage1-vs-Stage4 |
1.622490E-03 |
| Stage2-vs-Stage3 |
2.477000E-01 |
| Stage2-vs-Stage4 |
1.517370E-01 |
| Stage3-vs-Stage4 |
8.130400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.583000E-01 |
| Normal-vs-AfricanAmerican |
7.577800E-03 |
| Normal-vs-Asian |
8.234200E-01 |
| Caucasian-vs-AfricanAmerican |
3.502100E-02 |
| Caucasian-vs-Asian |
8.994600E-01 |
| AfricanAmerican-vs-Asian |
3.263000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.358430E-01 |
| Normal-vs-Female |
3.902800E-01 |
| Male-vs-Female |
5.756000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.269840E-01 |
| Normal-vs-Age(41-60Yrs) |
2.994800E-01 |
| Normal-vs-Age(61-80Yrs) |
1.910040E-01 |
| Normal-vs-Age(81-100Yrs) |
6.603400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.106200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.846400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.178600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.136600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.869600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.038200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.292600E-01 |
| Normal-vs-Grade 2 |
4.849800E-01 |
| Normal-vs-Grade 3 |
2.187500E-02 |
| Normal-vs-Grade 4 |
3.567500E-04 |
| Grade 1-vs-Grade 2 |
8.128600E-01 |
| Grade 1-vs-Grade 3 |
1.190260E-02 |
| Grade 1-vs-Grade 4 |
2.563500E-04 |
| Grade 2-vs-Grade 3 |
1.437540E-03 |
| Grade 2-vs-Grade 4 |
5.52229999999376E-05 |
| Grade 3-vs-Grade 4 |
1.923980E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.014600E-01 |
| Normal-vs-ccB subtype |
2.181700E-02 |
| ccA subtype-vs-ccB subtype |
2.381600E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.321000E-01 |
| Normal-vs-N1 |
8.18700000000394E-05 |
| N0-vs-N1 |
8.376000E-04 |
|
|
